Vaxart, Inc.

NASDAQ:VXRT

Biotechnology

Healthcare
$0.53 -1.75%

-$0.01 today

Market cap
$129.30M
Beta
1.09
P/E (TTM)
3.6
EPS (TTM)
$0.15
52W Low $0.26High $0.84

Volume 0.12M

Average 0.41M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$7.71M

FY 2025 · Annual

Investing Cash Flow

$16.63M

FY 2025 · Annual

Financing Cash Flow

$4.24M

FY 2025 · Annual

-92.5% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(70.47M)(107.76M)(82.47M)(66.95M)16.33M
Depreciation & Amortization4.21M5.81M8.62M8.85M8.58M
Deferred Income Tax3.09M4.09M000
Stock-Based Compensation8.87M13.59M14.13M11.5M8.31M
Change in Working Capital(2.12M)(4.7M)(10.85M)3.26M(22.56M)
Accounts Receivables263K51K(2.99M)(2.75M)(39.38M)
Inventory0(7.11M)000
Accounts Payables1.63M357K(2.44M)5.27M14.64M
Other Working Capital(4.01M)2M(5.42M)742K2.17M
Other Non-Cash Items(3.41M)(5.81M)106K(1.43M)(2.94M)
Operating Cash Flow(59.83M)(94.78M)(70.45M)(44.76M)7.71M
Capital Expenditures(5.16M)(9.6M)(1.87M)(554K)(145K)
Acquisitions (Net)(4.83M)10.81M120K00
Purchases of Investments(44.81M)(55.01M)(27.5M)(54.33M)(19.03M)
Sales of Investments5.7M44.2M73.2M43.5M40M
Other Investing Activities0(10.81M)0(9.95M)(4.2M)
Investing Cash Flow(49.1M)(20.42M)43.95M(21.32M)16.63M
Debt Repayment00000
Common Stock Issued122.21M17.24M15.03M56.78M4.44M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities3.59M225K213K(214K)(199K)
Financing Cash Flow125.8M17.46M15.24M56.56M4.24M
Effect of Forex Changes00000
Net Change in Cash16.88M(97.73M)(11.26M)(9.53M)28.59M
Free Cash Flow(64.99M)(104.38M)(72.32M)(45.32M)7.57M

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income$16.3M
+ D&A$8.6M
+ Stock-Based Comp$8.3M
+ Deferred Tax$0
- Working Capital-$22.6M
- Other Non-Cash-$2.9M
= Operating Cash Flow$7.7M
- Capex-$145.0K
= Free Cash Flow$7.6M

Analysis

FY2025 free cash flow is $7.6M. FCF conversion is 46.4% of net income. Operating cash flow was $7.7M, with capex of -$145.0K. The largest bridge item is Working Capital at -$22.6M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
DEFA14ADEFA14A filingJul 2, 2026
8-KCurrent reportJul 2, 2026
DFAN14ADFAN14A filingJul 2, 2026
DEFA14ADEFA14A filingJul 1, 2026
8-KCurrent reportJun 26, 2026

Does VXRT generate free cash flow?

Vaxart, Inc. (VXRT) generated $7.57M of free cash flow in fiscal 2025.

How much operating cash flow does VXRT produce?

Operating cash flow was $7.71M, before capital expenditures of $145,000.00.